未登录

N

Nádia Sitoe

world health organization

H指数:14

被引数:1,015

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Performance of two plasma separation devices for HIV-1 viral load measurement in primary healthcare settings

MICROBIOLOGY SPECTRUM

IF3.8

2023-12-124

OAAI

B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa

IF10.8

2023-07-017

OAAI

Effect of TB Treatment on Neutrophil-Derived Soluble Inflammatory Mediators in TB Patients with and without HIV Coinfection

IF3.3

2023-06-010

OAAI

Clinical Performance of Self-Collected Nasal Swabs and Antigen Rapid Tests for SARS-CoV-2 Detection in Resource-Poor Settings

在资源贫乏的环境中，自我收集的鼻拭子和抗原快速检测用于SARS-CoV-2检测的临床性能

IF3.9

2022-09-192

OAAI

Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of MTB-Specific CD4+ T-Cells in Relation to HIV Infection Status

通过与HIV感染状态相关的MTB特异性CD4 T细胞的表型特征来监测结核病治疗反应

IF3.3

2022-09-120

OAAI

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in the Mozambican Population: A Cross-Sectional Serologic Study in 3 Cities, July-August 2020

CLINICAL INFECTIOUS DISEASES

IF7.3

2022-06-244

OA

Performance Evaluation of the STANDARDTM Q COVID-19 and PanbioTM COVID-19 Antigen Tests in Detecting SARS-CoV-2 during High Transmission Period in Mozambique

IF3.3

2022-02-128

OAAI

Evaluation of the Whole-Blood Alere Q NAT Point-of-Care RNA Assay for HIV-1 Viral Load Monitoring in a Primary Health Care Setting in Mozambique

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2016-08-0138

OAAI

Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting

IF3.1

2016-01-0212

PREAI

Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study

IF88.5

2011-10-01230

PREAI

Accurate CD4 T-cell enumeration and antiretroviral drug toxicity monitoring in primary healthcare clinics using point-of-care testing

IF3.1

2011-03-2778

OA